Friday, May 20, 2016

BRIEF-Orbimed Advisors reports 7.40% stake in Intellia Therapeutics

* Orbimed Advisors LLC reports 7.40% stake in Intellia

Therapeutics as of May 11, 2016 - sec filing

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)